Daniel Nadler

Daniel Nadler

Daniel Nadler (#498)

We talk about the golden age of biotechnology where there are new drugs and better drugs developed all the time. But it is like the dark ages for physicians because of burnout.

  • $ 8 B
  • AI software
  • Canada
  • M
  • 42 Years

About Me

Daniel Nadler cofounded OpenEvidence in 2022 to use AI to help doctors make sense of the voluminous amount of medical research. OpenEvidence has reached a valuation of $12 billion after an early 2026 funding round. Nadler owns nearly 60% of the company. Before founding OpenEvidence, Nadler cofounded Kensho, which used AI for financial intelligence. He sold that company to S&P for $550 million in 2018. OpenEvidence has signed up more than 758,000 doctors, and is adding them at a rate of 55,000 per month. It's free for verified doctors, and makes its money from advertising.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Daniel Nadler’s rise and global influence.

  • #498   Billionaires (2026)

Wealth Growth

Net Worth Growth Over Time

Tracking Daniel Nadler’s net worth journey over the years, highlighting key growth phases and financial milestones.